Original Research

Published on 07 Nov 2024

ZNF350 gene polymorphisms promote the response to Peg-IFNα therapy through JAK-STAT signaling pathway in patients with chronic hepatitis B

in Viral Immunology

Qishui Ou
Ya Fu
Yongbin Zeng
Tianbin Chen
Jianhui Guo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1488055

277 views

Clinical Trial

Published on 07 Nov 2024

Risk factors for COVID-19 pneumonia in patients with hematological malignancies: a multi-center, prospective study in China

in Viral Immunology

Yao Liu
Jieping Li
Xiaoqing Xie
Shuang Chen
Zailin Yang
Haike Lei
Liu Yi
Li Jun

Frontiers in Immunology

doi 10.3389/fimmu.2024.1408969

263 views

Original Research

Accepted on 06 Nov 2024

Development of a Pan-Genotypic Monoclonal Antibody-Based Competitive ELISA for the Detection of Antibodies Against Bovine Viral Diarrhea Virus

in Viral Immunology

Shuhui Qi
Jing Wang
Ting Le
Chao Sun
Jitao Chang
Zhigang Jiang
Xin Yin
Quanhai Pang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1504115

117 views

Original Research

Accepted on 06 Nov 2024

Prognostic performance of early immune and endothelial activation markers in mild-to-moderate COVID-19 outpatients: a nested casecontrol study

in Viral Immunology

Andrea Alemany Ortiz
Núria Balanza
Pere Millat-Martinez
Dan Ouchi
Marc Corbacho-Monné
Cristian Morales-Indiano
Gema Fernández-Rivas
Ignacio Blanco
Oriol Mitjà
Ruth Aguilar

Frontiers in Immunology

doi 10.3389/fimmu.2024.1501872

Original Research

Accepted on 06 Nov 2024

Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement

in Viral Immunology

Elena Criscuolo
Benedetta Giuliani
Matteo Castelli
Mattia Cavallaro
Sofia Sisti
Roberto Burioni
Davide Ferrari
Nicasio Mancini
Locatelli Massimo
Nicola Clementi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1501200

Original Research

Accepted on 05 Nov 2024

Characteristics of cytokines/chemokines associated with disease severity and adverse prognosis in COVID-19 patients

in Viral Immunology

Jianghao Cheng
Haozhen Wang
Chaodan Li
Jianhua Yu
Mingli Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1464545

Original Research

Accepted on 04 Nov 2024

Long term COVID-19 vaccine-and Omicron infection-induced humoral and cellmediated immunity

in Viral Immunology

Milja Belik
Arttu Reinholm
Pekka Kolehmainen
Jemna Heroum
Sari Maljanen
Eda Altan
Pamela Österlund
Larissa Laine
Olli Ritvos
Arja Pasternack

Frontiers in Immunology

doi 10.3389/fimmu.2024.1494432

Correction

Accepted on 04 Nov 2024

Corrigendum: Immunological characteristics of a recombinant alphaherpesvirus with an envelope-embedded Cap protein of circovirus

in Viral Immunology

Chenhe Lu
Haimin Li
Wenjing Chen
Hui Li
Jiayu Ma
Peng Peng
Yan Yan
Weiren Dong
Yu-Lan Jin
Shiyue Pan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1515309

Original Research

Accepted on 04 Nov 2024

Spatial transcriptomics and in situ immune cell profiling of the host ectocervical landscape of HIV infected Kenyan sex working women

in Viral Immunology

Mathias Franzén Boger
Vilde Kaldhusdal
Anna Pascual-Reguant
Sandy Kroh
Ralf Uecker
Adam D Burgener
Julie Lajoie
Kenneth Omollo
Joshua Kimani
Keith R Fowke

Frontiers in Immunology

doi 10.3389/fimmu.2024.1483346

Original Research

Published on 04 Nov 2024

IP-10 acts early in CV-A16 infection to induce BBB destruction and promote virus entry into the CNS by increasing TNF-α expression

in Viral Immunology

Yunhui Zhang
Jie Song
Yajie Hu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1374447

393 views

Original Research

Published on 01 Nov 2024

Prediction of the risk of mortality in older patients with coronavirus disease 2019 using blood markers and machine learning

in Viral Immunology

Linchao Zhu
Yimin Yao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1445618

284 views

Original Research

Accepted on 30 Oct 2024

Defective proviruses significantly impact viral transcription and immune activation in men and women with HIV-1 subtype C in rural South Africa

in Viral Immunology

Ninée Veronique, Ernestine, Josephine Buchholtz
Lucas Etienne Hermans
CHIJIOKE UMUNNAKWE
Marieke Maria Nühn
Regina Voss
Emma Need
Neeltje Kootstra
Irma Maurer
Dorien C.M. de Jong
Jori Symons

Frontiers in Immunology

doi 10.3389/fimmu.2024.1484358

Original Research

Published on 30 Oct 2024

CRISPR/Cas9-mediated knockout of STAT1 in porcine-derived cell lines to elucidate the role of STAT1 in autophagy following classical swine fever virus infection

in Viral Immunology

Liyuan Zhang
Dongli Liang
Kaijun Min
Jiaxin Liang
Yu Tian
Cheng Liu
Ting Rong Luo
Xiaoning Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1468258

383 views

Original Research

Published on 29 Oct 2024

Antiviral immune response against HTLV-1 invalidates T-SPOT.TB® results in patients with HTLV-1-positive rheumatic diseases

in Viral Immunology

Masatoshi Kimura
Kunihiko Umekita
Chihiro Iwao
Katsumi Kawano
Yuki Hashikura
Yayoi Hashiba
Toshihiko Hidaka
Kenji Sugata
Yorifumi Satou
Taiga Miyazaki

Frontiers in Immunology

doi 10.3389/fimmu.2024.1480506

334 views

Review

Accepted on 28 Oct 2024

Research progress of spike protein mutation of SARS-CoV-2 mutant strain and antibody development

in Viral Immunology

Xinkang Huan
Hongwei Gao
Jiuyu zhan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1407149

Original Research

Published on 28 Oct 2024

BCR, not TCR, repertoire diversity is associated with favorable COVID-19 prognosis

in Viral Immunology

Faith Jessica Paran
Rieko Oyama
Abdullah Khasawneh
Tomohiko Ai
Hendra Saputra Ismanto
Aalaa Alrahman Sherif
Dianita Susilo Saputri
Chikako Ono
Mizue Saita
Satomi Takei

Frontiers in Immunology

doi 10.3389/fimmu.2024.1405013

539 views

Navigation group

Articles

ZNF350 gene polymorphisms promote the response to Peg-IFNα therapy through JAK-STAT signaling pathway in patients with chronic hepatitis B

Risk factors for COVID-19 pneumonia in patients with hematological malignancies: a multi-center, prospective study in China

Development of a Pan-Genotypic Monoclonal Antibody-Based Competitive ELISA for the Detection of Antibodies Against Bovine Viral Diarrhea Virus

Prognostic performance of early immune and endothelial activation markers in mild-to-moderate COVID-19 outpatients: a nested casecontrol study

Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement

Characteristics of cytokines/chemokines associated with disease severity and adverse prognosis in COVID-19 patients

Long term COVID-19 vaccine-and Omicron infection-induced humoral and cellmediated immunity

Corrigendum: Immunological characteristics of a recombinant alphaherpesvirus with an envelope-embedded Cap protein of circovirus

Spatial transcriptomics and in situ immune cell profiling of the host ectocervical landscape of HIV infected Kenyan sex working women

IP-10 acts early in CV-A16 infection to induce BBB destruction and promote virus entry into the CNS by increasing TNF-α expression

Prediction of the risk of mortality in older patients with coronavirus disease 2019 using blood markers and machine learning

Defective proviruses significantly impact viral transcription and immune activation in men and women with HIV-1 subtype C in rural South Africa

CRISPR/Cas9-mediated knockout of STAT1 in porcine-derived cell lines to elucidate the role of STAT1 in autophagy following classical swine fever virus infection

Antiviral immune response against HTLV-1 invalidates T-SPOT.TB® results in patients with HTLV-1-positive rheumatic diseases

Research progress of spike protein mutation of SARS-CoV-2 mutant strain and antibody development

BCR, not TCR, repertoire diversity is associated with favorable COVID-19 prognosis